2015

List of publications

  • Remodelage de la signalisation calcique dans la tumeur prostatique : signature moléculaire de la récidive du cancer de prostate après chirurgie ?Perrouin-Verbe M, Mignen O, Doucet L, Talagas M, Rosec S, Fournier G, Valeri A. Prog Urol. 2015 Nov;25(13):839.
  • Lipid rafts, KCa/ClCa/Ca(2+) channel complexes and EGFR signaling: Novel targets to reduce tumor development by lipids? Guéguinou M, Gambade A, Félix R, Chantôme A, Fourbon Y, Bougnoux P, Weber G, Potier-Cartereau M, Vandier C. Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2603-20.
  • Plasma membrane calcium channels in cancer: Alterations and consequences for cell proliferation and migration.Déliot N, Constantin B. Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2512-22.Review.
  • Sphaeropsidin A shows promising activity against drug-resistant cancer cells by targeting regulatory volume increase. Mathieu M, Chantôme A, Lefranc F, Cimmino A, Miklos W, Paulitschke,V, Mohr T, Maddau, L, Kornienko A, Berger W, Vandier C. Evidente A, Delpire E, and Kiss, R. Cell Mol Life Sci. 2015 Oct;72(19):3731-46.
  • Prospective directed to the synthesis of unsymmetrical linked bis-5-arylidene rhodanine derivatives via "one-pot two steps" reactions under microwave irradiation with their antitumor activity. Coulibaly WK, Paquin L, Bénie A, Bekro YA, Le Guével R, Ravache M, Corlu A, Bazureau JP. Medicinal Chemistry Research April 2015, Volume 24, Issue 4, pp 1653-1661
  • Ofatumumab capacity to deplete b cells from chronic lymphocytic leukaemia is affected by c4 complement exhaustion. Tempescul A, Bagacean C, Riou C, Bendaoud B, Hillion S, Debant M, Buors C, Berthou C, Renaudineau Y. Eur J Haematol. 2015 Apr 24.
  • Ofatumumab in a chronic lymphocytic leukemia patient with graft versus host disease and relapse after mini-allo BMT. Urian L, Renaudineau Y, Berthou C, Zdrenghea M, Petrov L, Tempescul A. J BUON. 2015 Mar-Apr;20(2):668-9.
  • Calcium signaling and cell fate: how can Ca (2+)signals contribute to wrong decisions for Chronic Lymphocytic Leukemic B lymphocyte outcome? Debant M, Hemon P, Brigaudeau C, Renaudineau Y, Mignen O. Int J Dev Biol. 2015;59(7-9):379-89.
  • CD5-expressing B-1 cells and infection. Infection and autoimmunity. Renaudineau Y Viale C, Youinou P. 2nd edition, pp :69-79.
  • Prospective directed to the synthesis of unsymmetrical linked bis-5-arylidene rhodanine derivatives via "one-pot two steps" reactions under microwave irradiation with their antitumor activity. Coulibaly WK, Paquin L, Bénie A, Bekro YA, Le Guével R, Ravache M, Corlu A, Bazureau JP. Medicinal Chemistry Research. 2015, 24, 1653-1661.

Patents

  • Brevet BNT218446EP00 (dépôt Europe, 6 aout 2015).
  • Brevet BNT218447FR00 (dépôt Europe, mars 2015).